Table 2.

Pairwise comparison between probiotics and rifaximin.

Rifaximin	–	0.47 (0.35–0.64)
0.56 (0.40–0.78)	Probiotics	0.84 (0.74–0.95)
0.47 (0.35–0.64)	0.84 (0.74–0.95)	Placebo

The top half showed the estimates of direct comparisons between two treatments, and the bottom half showed the estimates of network meta-analysis. Comparisons between treatments should be read from left to right, and the comparison estimate is in the cell between the column-defining treatment and the row-defining treatment. RRs > 1 favors row-defining treatment.

RR = relative ratio.